March 31st, 2021 3:30 – 6:00 pm (Paris Time Zone / CET)

MRNA vaccines have experienced an unprecedented burst  in basic and clinical research. These vaccines were among the first available vaccines to fight the Covid-19 pandemic and they demonstrated the potency and versatility of mRNA technology to protect against infectious disease. As this new delivery technology is going to be applied to hundreds of millions of people in the European Community and around the world, this webinar will present the key features of lipid nanoparticles (LNPs) used for the COVID-19 mRNA vaccine and will draw first lessons learned for further vaccine development and beyond for new mRNA therapies. Find out more.

Online registration